ATXS
Astria Therapeutics
ATXS
ATXS
Delisted
ATXS was delisted on the 22nd of January, 2026.
140 hedge funds and large institutions have $738M invested in Astria Therapeutics in 2025 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 33 increasing their positions, 31 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.99% less ownership
Funds ownership: 102.01% → 99.02% (-3%)
41% less call options, than puts
Call options by funds: $274K | Put options by funds: $466K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
140
Holding in Top 10
–
Calls
$274K
Puts
$466K
Top Buyers
| 1 | +$45.1M | |
| 2 | +$41M | |
| 3 | +$21.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$20M |
Top Sellers
| 1 | -$61.4M | |
| 2 | -$36.1M | |
| 3 | -$29.9M | |
| 4 |
Millennium Management
New York
|
-$29.9M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$25.9M |
